Signal active
Organization
Contact Information
Overview
Vaderis Therapeutics is a biotechnology company in the clinical stages that specializes in the treatment of uncommon and orphan diseases.
About
Biotechnology, Life Science
2019
11-50
Headquarters locations
Switzerland, Europe
Social
N/A
Profile Resume
Vaderis Therapeutics headquartered in Switzerland, Europe, operates in the Biotechnology, Life Science sector. The company focuses on Biotechnology and has secured $148.8M in funding across 8 round(s). With a team of 11-50 employees, Vaderis Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Vaderis Therapeutics, raised $18.6M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
1
1
0
$18.6M
Details
1
Vaderis Therapeutics has raised a total of $18.6M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Early Stage Venture | 18.6M |
Investors
Vaderis Therapeutics is funded by 3 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Giovanni Mariggi | - | FUNDING ROUND - Giovanni Mariggi | 18.6M |
Vaderis Therapeutics | - | FUNDING ROUND - Vaderis Therapeutics | 18.6M |
Medicxi | - | FUNDING ROUND - Medicxi | 18.6M |
Recent Activity
There is no recent news or activity for this profile.